M RA 5 (Rasagiline Mesylate 0.5 mg)
Pill with imprint M RA 5 is White, Round and has been identified as Rasagiline Mesylate 0.5 mg. It is supplied by Mylan Pharmaceuticals Inc..
Rasagiline is used in the treatment of parkinson's disease and belongs to the drug class dopaminergic antiparkinsonism agents. Risk cannot be ruled out during pregnancy. Rasagiline 0.5 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for M RA 5
Rasagiline Mesylate
- Imprint
- M RA 5
- Strength
- 0.5 mg
- Color
- White
- Size
- 6.00 mm
- Shape
- Round
- Availability
- Prescription only
- Drug Class
- Dopaminergic antiparkinsonism agents
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Mylan Pharmaceuticals Inc.
- National Drug Code (NDC)
- 00378-1270
- Inactive Ingredients
-
citric acid monohydrate,
silicon dioxide,
croscarmellose sodium,
microcrystalline cellulose,
corn starch,
stearic acid
Note: Inactive ingredients may vary.
Related Images for "M RA 5"
More about rasagiline
- Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Drug Images
- Drug Interactions
- Pricing & Coupons
- En Español
- 14 Reviews
- Drug class: dopaminergic antiparkinsonism agents
Consumer resources
- Other brands
- Azilect
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.